Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | ALPI | P09923 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | XIAP | P98170 | 1/20 | 0.44 |
| ▸ | GRIA1 | P42261 | 7/20 | 0.43 |
| ▸ | GRIA3 | P42263 | 7/20 | 0.43 |
| ▸ | GRIA2 | P42262 | 6/20 | 0.43 |
| ▸ | GRIA4 | P48058 | 6/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | GRIK1 | P39086 | 3/20 | 0.40 |
| ▸ | GRIK5 | Q16478 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.40 |
| ▸ | GRIK3 | Q13003 | 2/20 | 0.40 |
| ▸ | GRIK4 | Q16099 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5285204 | 1.00 | SLC7A5 (0.49) | SLC7A5CYP3A4ALPIPKMPTGS1 | |
| SCHEMBL22070454 | 0.83 | CYP3A4 (0.32) | SLC7A5CYP3A4CYP2C19HSD17B10 | |
| SCHEMBL5795469 | 0.81 | SLC7A5 (0.46) | SLC7A5CYP3A4ALPIPKMPTGS1 | |
| SCHEMBL8701275 | 0.80 | SLC7A5 (0.49) | SLC7A5CYP3A4ALPIPKMPTGS1 | |
| SCHEMBL17308615 | 0.80 | SLC7A5 (0.49) | SLC7A5CYP3A4ALPIPKMPTGS1 | |
| SCHEMBL5280033 | 0.80 | SLC7A5 (0.49) | SLC7A5CYP3A4ALPIPKMPTGS1 | |
| SCHEMBL28170277 | 0.80 | SLC7A5 (0.49) | SLC7A5CYP3A4ALPIPKMPTGS1 | |
| SCHEMBL17293244 | 0.80 | SLC7A5 (0.49) | SLC7A5CYP3A4ALPIPKMPTGS1 | |
| SCHEMBL17292898 | 0.80 | SLC7A5 (0.49) | SLC7A5CYP3A4ALPIPKMPTGS1 | |
| SCHEMBL17308685 | 0.79 | SLC7A5 (0.47) | SLC7A5CYP3A4ALPIPKMPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12565517-B2 | Cyclic peptide having CTLA-4 inhibitory activity and use thereof | GENEFRONTIER CORPORATION (JP) | 2026-03-03 | — | — | US | disclosed |
| WO-2026040002-A1 | COMPOSITION AND METHOD FOR CARING FOR THE SKIN | L'OREAL (FR) | 2026-02-26 | — | — | WO | disclosed |
| US-20240092836-A1 | CYCLIC PEPTIDE HAVING CTLA-4 INHIBITORY ACTIVITY AND USE THEREOF | GENEFRONTIER CORPORATION (JP) | 2024-03-21 | — | — | US | disclosed |
| CN-114599389-A | Variant FC domains and uses thereof | 奇达拉治疗公司 | 2022-06-07 | — | — | CN | disclosed |
| US-20100249042-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF EYELASHES AND EYEBROWS | PROCYTE CORPORATION (US) | 2010-09-30 | — | — | US | disclosed |
| EP-1613302-B1 | PRESERVED AND STABLE COMPOSITIONS CONTAINING PEPTIDE COPPER COMPLEXES AND METHODS RELATED THERETO | PROCYTE CORP (US) | 2009-12-23 | — | — | EP | disclosed |
| US-20080255032-A1 | METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING AGING OR PHOTODAMAGED SKIN | PROCYTE CORPORATION (US) | 2008-10-16 | — | — | US | disclosed |
| US-7384916-B2 | Methods and compositions for preventing and treating aging or photodamaged skin | PROCYTE CORPORATION (US) | 2008-06-10 | — | — | US | disclosed |
| EP-1866036-A2 | METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING AGING OR PHOTODAMAGED SKIN | PROCYTE CORPORATION (US) | 2007-12-19 | — | — | EP | disclosed |
| EP-1765280-A1 | METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING HYPERPIGMENTATION OF SKIN | PROCYTE CORPORATION (US) | 2007-03-28 | — | — | EP | disclosed |
| US-20040214749-A1 | Compositions and methods for treatment of psoriasis | PROCYTE CORPORATION (US) | 2004-10-28 | — | — | US | disclosed |
| WO-2004087740-A2 | PRESERVED AND STABLE COMPOSITIONS CONTAINING PEPTIDE COPPER COMPLEXES AND METHODS RELATED THERETO | PROCYTE CORPORATION (US) | 2004-10-14 | — | — | WO | disclosed |
| US-20040198639-A1 | Preserved and stable compositions containing peptide copper complexes and methods related thereto | PROCYTE CORPORATION | 2004-10-07 | — | — | US | disclosed |
| US-20040142853-A1 | Stimulation of hair growth by compositions containing peptide copper complexes and minoxidil | PROCYTE CORPORATION | 2004-07-22 | — | — | US | disclosed |
| WO-2004043415-A1 | STIMULATION OF HAIR GROWTH BY COMPOSITIONS CONTAINING PEPTIDE COPPER COMPLEXES AND MINOXIDIL | PROCYTE CORPORATION (US) | 2004-05-27 | — | — | WO | disclosed |
| EP-0765152-B1 | STIMULATION OF HAIR GROWTH BY PEPTIDE-COPPER COMPLEXES | PROCYTE CORP (US) | 2001-11-07 | — | — | EP | disclosed |
| US-6017888-A | Stimulation of hair growth by peptide copper complexes | PROCYTE CORPORATION (US) | 2000-01-25 | — | — | US | disclosed |
| EP-0765152-A1 | STIMULATION OF HAIR GROWTH BY PEPTIDE-COPPER COMPLEXES | PROCYTE CORPORATION (US) | 1997-04-02 | — | — | EP | disclosed |
| US-5538945-A | Stimulation of hair growth by peptide copper complexes | PROCYTE CORPORATION (US) | 1996-07-23 | — | — | US | disclosed |
| WO-1995035085-A1 | STIMULATION OF HAIR GROWTH BY PEPTIDE-COPPER COMPLEXES | PROCYTE CORPORATION (US) | 1995-12-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240092836-A1 | CYCLIC PEPTIDE HAVING CTLA-4 INHIBITORY ACTIVITY AND USE THEREOF | CXCL10, CXCR3, CXCR6 | SLC7A5 1763/4885CYP3A4 2636/4885ALPI 1986/4885 |
| US-12565517-B2 | Cyclic peptide having CTLA-4 inhibitory activity and use thereof | CXCL10, MLX, MICA | SLC7A5 1811/4885CYP3A4 2921/4885ALPI 1537/4885 |
| US-20040142853-A1 | Stimulation of hair growth by compositions containing peptide copper complexes and minoxidil | PDGFA, FGF1, FGF2 | SLC7A5 1616/4885CYP3A4 4276/4885ALPI 1911/4885 |
| US-20100249042-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF EYELASHES AND EYEBROWS | CUTA, TYR, EYA3 | SLC7A5 1624/4885CYP3A4 4834/4885ALPI 3945/4885 |
| US-20040214749-A1 | Compositions and methods for treatment of psoriasis | TYR, CUTA, ETF1 | SLC7A5 2905/4885CYP3A4 3746/4885ALPI 3338/4885 |
| US-20040198639-A1 | Preserved and stable compositions containing peptide copper complexes and methods related thereto | AOC1, NONO, CUTA | SLC7A5 2928/4885CYP3A4 3027/4885ALPI 3390/4885 |
| US-20080255032-A1 | METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING AGING OR PHOTODAMAGED SKIN | RBP1, RBP4, SOD1 | SLC7A5 1876/4885CYP3A4 4549/4885ALPI 2636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.